Brief advice on smoking reduction versus abrupt quitting for smoking cessation in Chinese smokers: a cluster randomized controlled trial by Lai, V et al.
Title
Brief advice on smoking reduction versus abrupt quitting for
smoking cessation in Chinese smokers: a cluster randomized
controlled trial
Author(s) Wang, MP; Li, WHC; Cheung, YTD; Lam, OBC; WU, Y; Kwong, A;Lai, V; Chan, SSC; Lam, TH
Citation Nicotine & Tobacco Research, 2017, v. 20 n. 1, p. 67-72
Issued Date 2017
URL http://hdl.handle.net/10722/239491
Rights
This is a pre-copy-editing, author-produced PDF of an article
accepted for publication in Nicotine & Tobacco Research
following peer review. The definitive publisher-authenticated
version Nicotine & Tobacco Research, 2017, v. 20 n. 1, p. 67-72
is available online at: https://academic.oup.com/ntr/article-
abstract/20/1/67/2981787?redirectedFrom=fulltext; This work is
licensed under a Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License.
Original investigation
Brief Advice on Smoking Reduction Versus 
Abrupt Quitting for Smoking Cessation in 
Chinese Smokers: A Cluster Randomized 
Controlled Trial
Man Ping Wang1, William H. Li1, Yee Tak Cheung1,2, Oi Bun Lam1, Yongda Wu1, 
Antonio C. Kwong3, Vienna W. Lai3, Sophia S. Chan1, Tai Hing Lam2 
1School of Nursing, University of Hong Kong; 2School of Public Health, University of Hong Kong; 3Hong Kong Council 
on Smoking and Health
Corresponding Author: Man Ping Wang, PhD, School of Nursing, University of Hong Kong, Pokfulam, Hong Kong, China. 
Telephone: 852-39176636; Fax: 852-28726079; E-mail: mpwang@hku.hk
Abstract
Aims: To compare the efﬁcacy of brief advice about cut-down-to-quit (CDTQ) with that of brief 
advice about quit immediately (QI), as delivered by trained volunteers, without the use of phar-
macological therapy, to outreach-recruited Chinese smokers in Hong Kong who intend to quit 
smoking.
Methods: Smokers (N = 1077) who enrolled in the Quit and Win Contest 2014 and intended to quit 
or reduce smoking were randomized in participation sessions to CDTQ (n = 559) and QI (n = 518) 
groups. Subjects in the CDTQ group received brief advice and a card about smoking reduction. 
Subjects in the QI group received brief advice and a leaﬂet about quitting smoking. All received a 
smoking cessation booklet and corresponding CDTQ or QI brief telephone advice at intervals of 
1 week, 1 month, or 2 months. The primary outcomes were self-reported 7-day point prevalence 
abstinence (PPA) at the 3-month and 6-month follow-ups. The secondary outcomes included absti-
nence rate as validated by biochemical tests, smoking reduction (≥50% reduction from baseline), 
and quit attempt (QA). The outcome assessors were blinded as to group assignment.
Results: By intention to treat, the QI and CDTQ groups showed similar results as regards (a) self-
reported PPA (10.6% [95% CI 8.1%–13.6%] vs. 9.1% [95% CI 6.9%–11.8%]), (ii) validated abstinence 
rate (5.6% [3.8%–7.9%] vs. 5.4% [3.6%–7.6%]), and (iii) QA rate (59.2% [53.5%–64.8%] vs. 54.1% 
[48.7%–59.3%]) at 6-month. However, the CDTQ group showed a signiﬁcantly higher reduction rate 
than the QI group (20.9% [CI 17.6%–24.5%] vs. 14.5% [11.6%–17.8%]). The overall intervention adher-
ence was suboptimal (45.4%), particularly in the CDTQ group (42.3%). Self-efﬁcacy as regards quit-
ting of smoking was similar between the groups at 6 months.
Conclusions: Brief advice on CDTQ and QI had similar short-term PPAs. Longer-term follow-up is 
needed to understand the latent effect of smoking reduction on abstinence.
Implications: This is the ﬁrst randomized controlled trial in ethnic Chinese smokers to evaluate the 
relative efﬁcacy of brief advice on (a) CDTQ and (b) QI as regards quitting. The two interventions 
showed similar effects as regards PPA. The ﬁndings suggested that brief advice on CDTQ may be 
as effective as brief advice on QI in smokers recruited in community settings.
2Introduction
Cut-down-to-quit (CDTQ) is an alternative approach to quitting 
abruptly. It envisages reducing the number of cigarettes gradually 
to achieve total abstinence. The CDTQ approach is controversial as 
regards its efficacy in achieving harm reduction and smoking cessa-
tion. Meta-analysis studies found similar quit rates between CDTQ 
and quit immediately (QI) interventions in smokers with or without 
intention to quit smoking.1,2 Subgroup analysis of limited nonphar-
macologic studies of the meta-analysis showed similar quit rates in 
CDTQ and QI groups in smokers who wanted to quit smoking.1 
Two recent randomized controlled trials (RCT) found that, among 
smokers without intention to quit smoking, CDTQ intervention 
without medication yielded similar point prevalence abstinence 
(PPA) results as compared with other QI or motivational counseling, 
but better PPA than no intervention or usual care.3,4 The smoking 
cessation effects of CDTQ intervention combined with nicotine 
replacement therapy (NRT) differed by whether there was initial 
intention to quit.1,5,6 In two meta-analysis studies, when CDTQ was 
combined with NRT (with or without behavioral support) it dou-
bled the sustained quit rate in smokers who had no initial intention 
to quit5 but produced only a similar sustained quit rate in smokers 
who had expressed an intention to quit.1 Another recent RCT on 
NRT-assisted CDTQ in smokers who attended general practitioner 
clinics and were willing to quit found significantly lower PPA for the 
CDTQ intervention as compared with QI (relative risk 0.71, 95% CI 
0.46–0.91) at the 6-month follow-up.6
Most CDTQ studies have been carried out in Western subjects. 
Only one trial has been conducted on Chinese subjects.7 Our earlier 
RCT found that smoking reduction counseling combined with NRT 
was more effective than brief advice on QI as assessed by PPA rates 
at the 6-month follow-up (17.0% vs. 10.2%, p  =  .01) in Chinese 
smokers who had not expressed an intention to quit.8 Subsequent 
posteriori analysis of the same study found that smoking reduc-
tion counseling was more effective in achieving total abstinence in 
hardcore smokers than in non-hardcore smokers,9 and that a greater 
percentage of smoking reduction predicted abstinence.10 Smoking 
reduction intervention may be particularly important for countries 
where smoking prevalence is decreasing in the population, and 
hardcore smokers predominate. Hong Kong is a typical example 
of such a situation, in particular after the implementation of strong 
smoke-free legislation and other tobacco control measures.11 Many 
reduction trials have involved pharmacologic therapies. It remains 
uncertain whether smoking reduction counseling alone is effective 
in smokers who are willing to quit or reduce smoking. Unlike earlier 
trials that used intensive smoking reduction consultation, we aimed 
to test a short brief advice on reduction to achieve smoking absti-
nence among Chinese smokers in Hong Kong.
Methods
Design
This cluster randomized controlled trial (cRCT) recruited Chinese 
adult smokers in Hong Kong. The subjects were randomized to 
receive brief advice at recruitment sessions about either CDTQ or QI 
for smoking cessation. At baseline, the CDTQ group received brief 
advice and a card on smoking reduction; thereafter, on follow-up, 
they received brief smoking reduction advice over the telephone. The 
QI group received brief QI advice and a QI card, and brief smok-
ing cessation advice over the telephone at follow-up. Both groups 
received a 12-page self-help booklet on smoking cessation. Please 
refer to Supplementary Material for a brief description of self-help 
booklet and cards. The primary outcomes were self-reported PPA 
values for the past 7 days, at 3-month and 6-month follow-ups.
Subjects
The subjects were smokers who joined the Quit and Win Contest in 
2014. The contest provided incentives to promote quitting of smok-
ing: the details of the recruitment procedure have been published 
elsewhere.12 In brief, trained smoking cessation ambassadors actively 
recruited adult smokers from the community in all 18 districts of 
Hong Kong. Smokers who had smoked at least 1 cigarette daily in 
the past 3 months, had an expiratory carbon monoxide (CO) con-
centration of at least 4 ppm and expressed a willingness to reduce 
or quit smoking were eligible to participate in the trial. We excluded 
smokers who were non-Chinese, of ages <18 or who had partici-
pated in other smoking cessation programs. The sample size was 
estimated based on the assumption of 5% significant level, 80% 
power and the finding from the earlier CDTQ trial which showed 
an odds ratio/effect size of 1.67.8 Assuming a 60% retention rate 
and intra-cluster correlation coefficient of 0.01, the sample size was 
calculated as 1252 smokers.
Randomization
Cluster randomization based on recruitment sessions (N = 67) was 
used as onsite individual randomization would be subject to con-
tamination. All subjects recruited from the same session were ran-
domly allocated to either the CDTQ group or the QI group, using 
permuted block randomization. The primary investigator, who was 
not involved in the recruitment, randomly generated blocks, with 
each block size being equal to 4 and containing a random permuta-
tion of the 2 groups. All the blocks were combined to generate the 
list of group allocation. The recruitment staff was informed about 
the group allocation one day prior to the recruitment session. The 
subjects were not informed about the intervention in other groups. 
Outcome assessors and statistical analysts were blinded as to the 
group allocation.
Interventions
Subjects in the CDTQ group received brief advice (about 5 minutes) 
on smoking reduction. The briefing used the AWARD model13 which 
includes (a) Ask about smoking history, (b) Warn about the health 
risk (that one in every two smokers would die of smoking-related 
causes), (c) Advise to quit by cutting down cigarette consumption at 
their own pace within 3 months, (d) Refer the smokers to a smok-
ing cessation clinic, and (e) Do it again by repeating the interven-
tion during each telephone follow-up and encouraging smokers who 
relapse to restart smoking reduction. The smoking cessation ambas-
sadors helped the subjects to set strategies for gradual reduction: 
progressively reduce cigarettes smoked per day by 25% in the first 
week, 50% in the first month, 75% in the second month and quit 
altogether in the third month14; use a scheduled reduction approach 
by increasing time intervals between each cigarette,15 or a hierar-
chical reduction approach starting with the easiest cigarette of the 
day to forgo and moving to the hardest cigarette to give up (or vice 
versa).16 Subjects also received a smoking reduction card containing 
the above information. Subjects in the CDTQ group who planned to 
quit within 7 days were encouraged to quit and received a reduction 
card if they would like to reduce smoking after the 7-day. Those who 
3failed to quit in 7-day would receive the same CDTQ brief advice 
through telephones at 1-week follow-up. Smokers who quit within 
7 days were encouraged during follow-ups to remain abstinent. The 
subjects also received brief ‘booster’ messages (1–2 minutes) over 
the telephone to reinforce the reduction advice at 1 week, 1 month, 
and 2 months. The subjects in the QI group received AWARD advice 
(about 5 minutes) focusing on QI13 and our ambassadors encour-
aged them to set a quit day close to baseline. A QI card and brief 
QI booster messages over the telephone were also provided as for 
the CDTQ group. At baseline, both groups were given a standard 
12-page smoking cessation booklet designed by the Hong Kong 
Council on Smoking and Health (COSH).17
Measures and Statistical Analysis
Based on interviews, each subject completed a questionnaire on soci-
odemographic characteristics, smoking and quit history, nicotine 
dependence as measured by Heaviness of Smoking Index (HSI),18 
and perceived self-efficacy (difficulties, importance assigned and con-
fidence) as regards quitting of smoking.19,20 The primary outcomes 
were measured in terms of the self-reported past-7-day PPA at the 
3-month and 6-month telephone follow-ups. The secondary out-
comes included biochemically validated (salivary cotinine <10 ng/
mL) abstinence rate, smoking reduction (≥50% reduction from base-
line), and QA (any abstinence attempt lasting 24 hours or longer 
after participating in the project). Logistic regression was used to 
calculate odds ratios (ORs) of outcomes between the CDTQ and QI 
groups, using intention to treat (ITT) and complete case analysis. We 
also compared group prevalences of indicators of intervention com-
pliance, which included whether the subjects read the booklet (ever 
vs. never), read the education cards (ever vs. never) and followed the 
instructions (yes vs. no).
Ethical Approval
The study was approved by the Institutional Review Broad of the 
University of Hong Kong/Hospital Authority West Cluster (UW 
14-382) and registered in trial registry (NCT02539875).
Results
Of 1328 smokers assessed for eligibility, 1077 were selected and ran-
domized to CDTQ (n = 559) and QI (n = 518) groups. Retention 
rates were 65.3% in the CDTQ group and 60.8% in the QI group 
at 3 months follow-up, and fell to 63.9% and 58.7%, respectively, 
at 6 months (Figure 1). The subjects were 42 (±15.5) years of age on 
average; 81.4% were male subjects; 83.8% had at least a secondary 
school education;, 55.8% had monthly family income <HK$20 000 
(US$2564); and 75.5% were employed. Both groups shared very 
similar smoking and quitting histories, which included average age 
at which smoking started, CO concentration, proportions of quit 
and reduction attempts in the last 12-month, and self-perceived 
efficacy as regards quitting (Table 1). The CDTQ group had a sig-
nificantly higher proportion of subjects in paid employment, higher 
daily cigarette consumption and higher nicotine dependence level 
(HSI score ≥ 4).
Self-reported PPA was nonsignificantly lower in the CDTQ group 
than in the QI group at 3 months (7.0% vs. 10.0%; OR 0.67, 95% 
CI 0.44–1.04) and 6 months (9.1% vs. 10.6%; OR 0.85, 95% CI 
0.57–1.26) (Table  2). Biochemically validated abstinence rates 
were also nonsignificantly lower in the CDTQ group (3.8%) than 
in the QI group 5.6% (OR 0.63 95% CI 0.36–1.12) at 3 months, 
and this difference dipped at 6-months (5.4% vs. 5.6%; OR 0.96, 
95% CI 0.57–1.62). Smoking reduction (≥50%) rates progressively 
increased in the CDTQ group between the 1-month and 6-month 
follow-ups, whereas they gradually reduced in the QI group dur-
ing the same period. The absolute difference in point prevalence of 
smoking reduction between the CDTQ and QI groups increased 
from −7.1% at 1 month to 6.5% at 6 months. The smoking reduc-
tion rate was significantly higher in the CDTQ group (20.9%) than 
in the QI group (14.5%) at the 6-month follow-up (OR 1.56, 95% 
CI 1.14–2.15). Past QA rates (defined as QA after joining the pro-
ject) were similar between the two groups at follow-up. The results 
remained robust after adjusting for demographic characteristics and 
baseline HSI.
The rates of use of booklets (63.2%) and education cards 
(73.2%) were satisfactory (Table 3) but less than half (45.4%) of the 
subjects were adherent to the suggested quitting methods. Subjects 
in the CDTQ group (42.3%) had a marginally significant lower rate 
of compliance to the suggested quitting methods than subjects in the 
QI group (49.0%) at 6 months (p = .08). The subjects’ levels of self-
perceived efficacy in quitting smoking were similar between groups.
Discussion
This cRCT has a larger sample size compared to earlier trials that 
were included in a meta-analysis on the effectiveness of smoking 
reduction advice and behavioral support on smoking abstinence.1 
We found similar self-reported PPA values, validated abstinence 
rates and QA between the CDTQ and QI groups of ethnic Chinese 
Assessed for eligibility (n= 1,328)
Excluded (n=251)
Not eligible for the Contest (n=2)
Refused to consent (n=19)
Joined non-RCT (n=230)
Allocated to QI group (n=518) Allocated to CDTQ group (n=559)
Cluster randomization (n=1077)
1-week follow-up and interventions
462 completed (82.6%)
94 lost contact (16.8%)
3 refused (0.5%)
1-week follow-up and interventions
406 completed (78.4%)
97 lost contact (18.7%)
15 refused (2.9%)
1-month follow-up and interventions
407 completed (72.8%)
146 lost contact (26.1%)
6 refused (1.1%)
1-month follow-up and interventions
355 completed (68.5%)
137 lost contact (26.4%)
26 refused (5.0%)
3-month follow-up
365 completed (65.3%)
155 lost contact (27.7%)
39 refused (7.0%) 
3-month follow-up
315 completed (60.8%)
154 lost contact (29.7%)
49 refused (9.5%) 
6-month follow-up
357 completed (63.9%)
148 lost contact (26.5%)
54 refused (9.7%)
6-month follow-up
304 completed (58.7%)
150 lost contact (29.0%)
64 refused (12.4%)
2-month follow-up and interventions
360 completed (64.4%)
183 lost contact (32.7%)
16 refused (2.9%)
2-month follow-up and interventions
355 completed (68.5%)
138 lost contact (26.6%)
25 refused (4.8%)
Figure 1. Trial ﬂow chart.
4daily smokers at follow-ups at 3 months and 6 months. The find-
ings were different from our earlier trial in which CDTQ plus NRT 
was found to be effective in helping to achieve abstinence among 
smokers who had not been ready to quit smoking.8 A meta-analysis 
also found that CDTQ plus medication was more effective in boost-
ing abstinence among smokers who were not ready to quit.7 Our 
findings, however, were consistent with the systematic reviews on 
CDTQ plus either medication or nonpharmacologic interventions 
such as counseling and behavioral support.1,2 Smoking reduction is 
commonly adopted by habitual smokers and brief advice is often 
offered by smoking cessation services providers (eg, quitlines) in 
Hong Kong and elsewhere.21 Our findings suggest that, in smokers 
who intend to quit smoking, brief advice on CDTQ may have simi-
lar effects on quitting as advice on QI. CDTQ may be particularly 
useful for smokers who are unwilling to quit or have had difficulties 
in quitting. Smoking reduction may improve health and increase the 
likelihood of success in quitting in the future.22
A possible explanation for the similarity in quit rates between 
the CDTQ and QI groups could be that CDTQ requires an under-
standing of the reduction strategies and a proper monitoring of the 
number of cigarettes consumed or reduced. These may be difficult 
to follow for elderly smokers and those with lower education levels. 
This theory is supported by our further subgroup analyses which 
showed that old age (9.1% aged ≥65 years) and education only up 
to primary level (16.2%) were associated with low odds of smoking 
reduction and cessation in the CDTQ group at follow-up (data not 
shown in table), although the interaction effects of age and educa-
tion on the outcomes were not statistically significant. More than 
Table 1. Baseline Subject Characteristics
CDTQ (n = 559) QI (n = 518) p value
Male 82.6 80.1 .27
Mean age (±SD), year 42.8 ± 14.7 42.6 ± 16.4 .86
Secondary education or above 84.1 83.6 .84
In-paid employment 78.3 72.6 .03
Living in rental public housing 43.5 45.4 .52
Monthly household income <HKD 20 000 (7.8 = 1USD) 53.9 57.8 .21
Mean age of starting smoking (±SD), year 17.6 ± 5.9 17.5 ± 6.0 .98
Mean daily cigarette consumption (±SD) 16.2 ± 9.5 14.7 ± 8.5 .01
Mean expired CO concentration (±SD), ppm 20.0 ± 12.8 19.3 ± 13.0 .21
Higher nicotine dependence (HSI score ≥ 4) 38.5 32.2 .03
No previous quit attempt 27.2 24.7 .37
Any quit attempt(s) in the last 12 months 23.1 27.3 .11
Any smoking reduction attempt(s) in the last 12 months 29.5 32.1 .37
Self-efficacy on quitting (mean ± SD)a
 Perceived difficulty 7.4 ± 2.4 7.2 ± 2.5 .41
 Perceived confidence 5.6 ± 2.4 5.8 ± 2.3 .31
 Perceived importance 7.8 ± 2.2 7.8 ± 2.3 .62
CDTQ = cut-down-to-quit; CO = carbon monoxide; HSI = Heaviness of Smoking Index; QI = quit immediately.
aScore 0–10, higher score indicates higher levels of perception.
Table 2. Smoking Cessation Outcomes
CDTQ, n (%) QI, n (%) Absolute difference (95% CI), % point Odds ratio (95% CI) Adjusted odds ratioa (95% CI)
Self-report abstinence
 1-month 26 (4.7) 43 (8.3) −3.7 (−6.6 to −0.7) 0.54 (0.33 to 0.89)* 0.59 (0.35 to 0.96)*
 2-month 30 (5.4) 58 (11.2) −5.8 (−9.1 to −2.5) 0.45 (0.28 to 0.71)** 0.45 (0.28 to 0.73)**
 3-month 39 (7.0) 52 (10.0) −3.1 (−6.4 to 0.3) 0.67 (0.44 to 1.04) 0.71 (0.45 to 1.11)
 6-month 51 (9.1) 55 (10.6) −1.5 (−5.1 to 2.1) 0.85 (0.57 to 1.26) 0.87 (0.57 to 1.32)
Validated abstinenceb
 3-month 21 (3.8) 29 (5.6) −1.8 (−4.4 to 0.7) 0.63 (0.36 to 1.12) 0.72 (0.40 to 1.29)
 6-month 30 (5.4) 29 (5.6) −0.2 (−3.0 to 2.5) 0.96 (0.57 to 1.62) 0.99 (0.58 to 1.70)
Smoking reduction by 50%
 1-month 107 (19.1) 136 (26.3) −7.1 (−12.1 to −2.1) 0.49 (0.36 to 0.67)*** 0.50 (0.36 to 0.70)***
 2-month 103 (18.4) 119 (23.0) −4.5 (−9.4 to 0.3) 0.67 (0.49 to 0.94)* 0.71 (0.50 to 0.99)*
 3-month 136 (24.3) 113 (21.8) 2.5 (−2.5 to 7.5) 0.95 (0.68 to 1.32) 1.00 (0.72 to 1.41)
 6-month 117 (20.9) 75 (14.5) 6.5 (1.9 to 11.0) 1.56 (1.14 to 2.15)** 1.54 (1.11 to 2.14)**
Quit attemptc
 3-month 117 (32.1) 124 (39.4) −7.3 (−14.5 to −0.1) 0.73 (0.53 to 1.00)* 0.78 (0.56 to 1.08)
 6-month 142 (39.8) 125 (41.1) −1.3 (−8.9 to 6.2) 0.95 (0.69 to 1.29) 1.07 (0.77 to 1.49)
CDTQ = cut-down-to-quit; CI = confidence interval; HIS = Heaviness of Smoking Index; QI = quit immediately.
aAdjusting for age, sex, employment status, and HSI.
bValidated by salivary cotinine < 10 mg/mL.
cExcluded quitters.
*p < .05; **p < .01; ***p < .001.
570% of the subjects in the CDTQ group did read and refer to the 
education card. The adherence rate to the suggested quitting strate-
gies was marginally significantly lower in the CDTQ group (42.3%) 
than in the QI group (49.0%). Another explanation for these find-
ings could be that the brief advice given to the subjects in the CDTQ 
group was not comprehensive enough to deliver an understanding 
of the reduction strategies, and that these may require more detailed 
explanations as compared to the advice given to subjects in the QI 
group. On the other hand, brief advice is a more feasible interven-
tion than intensive counseling for recruiting smokers in commu-
nity settings (eg, shopping malls, streets and housing estate public 
areas, etc.) and intensive counseling may be unacceptable to some 
smokers.
Smoking reduction may require a longer time to practice and 
move toward achieving abstinence. We observed that the smok-
ing reduction rate gradually increased between the 1-month and 
6-month follow-ups in the CDTQ group but declined during the 
same time line in the QI group. This suggests that smokers in the 
CDTQ group may require more than a 6-month period to practice 
the strategies to reduce cigarette consumption ≥50% and to achieve 
abstinence. Our previous trial using NRT to help gradual cessation 
in smokers found that smoking reduction predicted subsequent 
abstinence,10 which was consistent with a recent UK study which 
showed that smokers who used NRT consciously attempted to 
reduce cigarette consumption.23 Longer-term studies, such as those 
involving 1-year follow-up, are needed to evaluate the effectiveness 
of CDTQ in achieving smoking abstinence.
This study had several limitations. First, the discrepancy between 
self-reported PPA and validated abstinence rates suggested that self-
reported PPA might be overestimated as a result of a lack of evidence 
about which group was particularly affected. However, validated 
abstinence rates were very similar between CDTQ and QI groups 
(5.4% vs. 5.6%), suggesting that the conclusions were unlikely to 
have been affected by the overestimated self-reported abstinence. 
Second, smoking reduction was not validated by biochemical tests, 
such as exhaled CO or saliva cotinine. However, the validity of bio-
chemical tests on smoking reduction has not been well established, 
particularly among heavy smokers.24 Third, 38.7% of the subjects 
were lost by the 6-month follow-up. Although the proportions of 
loss to follow-up were similar in both groups and the use of inten-
tion-to-treat might reduce the bias, the findings should be interpreted 
with caution. Fourth, although the small proportion of female smok-
ers (18.6%) in our study reflected the general prevalence of female 
smokers in Hong Kong, the results may not be generalizable to 
Western countries where female smoking is more common. Given 
that all the subjects were enrolled to win prizes in the Quit and Win 
Contest, the findings of this trial may not be directly comparable to 
other smoking reduction trials.
Conclusions
Brief advice on CDTQ and QI achieved similar short-term PPA in 
smokers enrolled in the 2014 Quit and Win Contest in Hong Kong. 
A longer-term follow-up is needed to understand the latent effect of 
smoking reduction in the CDTQ group on abstinence.
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online.
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